Business Description
CalciMedica Inc
NAICS : 541714
SIC : 2834
ISIN : US38942Q2021
Share Class Description:
CALC: Ordinary SharesDescription
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need. Its proprietary technology targets the inhibition of calcium release-activated calcium channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases for which there are no approved therapies.
Financial Strength
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.64 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 50.3 | |||||
3-Year EPS without NRI Growth Rate | 51.5 | |||||
3-Year FCF Growth Rate | 56.5 | |||||
3-Year Book Growth Rate | -71.8 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 46.77 | |||||
9-Day RSI | 43.21 | |||||
14-Day RSI | 42.6 | |||||
6-1 Month Momentum % | 62.57 | |||||
12-1 Month Momentum % | 44.78 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 6.21 | |||||
Quick Ratio | 6.21 | |||||
Cash Ratio | 6 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -56.6 | |||||
Shareholder Yield % | -42.13 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -98.54 | |||||
ROA % | -67.86 | |||||
ROIC % | -4721.56 | |||||
ROC (Joel Greenblatt) % | -10396.47 | |||||
ROCE % | -108.56 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 2.65 | |||||
Price-to-Tangible-Book | 2.65 | |||||
EV-to-EBIT | -0.39 | |||||
EV-to-Forward-EBIT | -0.29 | |||||
EV-to-EBITDA | -0.39 | |||||
EV-to-Forward-EBITDA | -0.29 | |||||
EV-to-FCF | -0.27 | |||||
Price-to-Net-Current-Asset-Value | 2.73 | |||||
Price-to-Net-Cash | 2.9 | |||||
Earnings Yield (Greenblatt) % | -256.41 | |||||
FCF Yield % | -54.79 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:CALC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
CalciMedica Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -2.15 | ||
Beta | 0.68 | ||
Volatility % | 203.78 | ||
14-Day RSI | 42.6 | ||
14-Day ATR ($) | 0.497013 | ||
20-Day SMA ($) | 4.80825 | ||
12-1 Month Momentum % | 44.78 | ||
52-Week Range ($) | 1.75 - 8.38 | ||
Shares Outstanding (Mil) | 10.75 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
CalciMedica Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
CalciMedica Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
CalciMedica Inc Frequently Asked Questions
What is CalciMedica Inc(CALC)'s stock price today?
The current price of CALC is $4.26. The 52 week high of CALC is $8.38 and 52 week low is $1.75.
When is next earnings date of CalciMedica Inc(CALC)?
The next earnings date of CalciMedica Inc(CALC) is 2024-08-09 Est..
Does CalciMedica Inc(CALC) pay dividends? If so, how much?
CalciMedica Inc(CALC) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |